These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7780966

  • 21. Involvement of activator protein-1 and nuclear factor-kappaB transcription factors in the control of the DT-diaphorase expression induced by mitomycin C treatment.
    Yao KS, Hageboutros A, Ford P, O'Dwyer PJ.
    Mol Pharmacol; 1997 Mar; 51(3):422-30. PubMed ID: 9058597
    [Abstract] [Full Text] [Related]

  • 22. No role of DT-diaphorase (NQO1) in the protection against oxidized quercetin.
    Boots AW, Bast A, Haenen GR.
    FEBS Lett; 2005 Jan 31; 579(3):677-82. PubMed ID: 15670828
    [Abstract] [Full Text] [Related]

  • 23. Effects of hypoxia on detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells.
    O'Dwyer PJ, Yao KS, Ford P, Godwin AK, Clayton M.
    Cancer Res; 1994 Jun 15; 54(12):3082-7. PubMed ID: 8205521
    [Abstract] [Full Text] [Related]

  • 24. Quantitation of estrogen receptor mRNA and its alternatively spliced mRNAs in breast tumor cells and tissues.
    Fasco MJ.
    Anal Biochem; 1997 Feb 15; 245(2):167-78. PubMed ID: 9056208
    [Abstract] [Full Text] [Related]

  • 25. Demonstration of the activation of prodrug CB 1954 using human DT-diaphorase mutant Q104Y-transfected MDA-MB-231 cells and mouse xenograft model.
    Wu K, Eng E, Knox R, Chen S.
    Arch Biochem Biophys; 2001 Jan 01; 385(1):203-8. PubMed ID: 11361019
    [Abstract] [Full Text] [Related]

  • 26. Increased NAD(P)H:(quinone-acceptor)oxidoreductase activity is associated with density-dependent growth inhibition of normal but not transformed cells.
    Schlager JJ, Hoerl BJ, Riebow J, Scott DP, Gasdaska P, Scott RE, Powis G.
    Cancer Res; 1993 Mar 15; 53(6):1338-42. PubMed ID: 8443814
    [Abstract] [Full Text] [Related]

  • 27. Over-expression of DT-diaphorase in transfected NIH 3T3 cells does not lead to increased anticancer quinone drug sensitivity: a questionable role for the enzyme as a target for bioreductively activated anticancer drugs.
    Powis G, Gasdaska PY, Gallegos A, Sherrill K, Goodman D.
    Anticancer Res; 1995 Mar 15; 15(4):1141-5. PubMed ID: 7653992
    [Abstract] [Full Text] [Related]

  • 28. Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display.
    Chung JG, Yeh KT, Wu SL, Hsu NY, Chen GW, Yeh YW, Ho HC.
    Cancer Res; 2001 Dec 15; 61(24):8873-9. PubMed ID: 11751411
    [Abstract] [Full Text] [Related]

  • 29. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues.
    Saebøe-Larssen S, Fossberg E, Gaudernack G.
    BMC Mol Biol; 2006 Aug 29; 7():26. PubMed ID: 16939641
    [Abstract] [Full Text] [Related]

  • 30. Gene targeting of DT-diaphorase in mouse embryonic stem cells: establishment of null mutant and its mitomycin C-resistance.
    Yoshida T, Tsuda H.
    Biochem Biophys Res Commun; 1995 Sep 14; 214(2):701-8. PubMed ID: 7677784
    [Abstract] [Full Text] [Related]

  • 31. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.
    Knox RJ, Jenkins TC, Hobbs SM, Chen S, Melton RG, Burke PJ.
    Cancer Res; 2000 Aug 01; 60(15):4179-86. PubMed ID: 10945627
    [Abstract] [Full Text] [Related]

  • 32. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity.
    Kuehl BL, Paterson JW, Peacock JW, Paterson MC, Rauth AM.
    Br J Cancer; 1995 Sep 01; 72(3):555-61. PubMed ID: 7669561
    [Abstract] [Full Text] [Related]

  • 33. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
    Qiu XB, Cadenas E.
    Arch Biochem Biophys; 1997 Oct 15; 346(2):241-51. PubMed ID: 9343371
    [Abstract] [Full Text] [Related]

  • 34. Arsenite and cadmium, but not chromium, induce NAD(P)H:quinone oxidoreductase 1 through transcriptional mechanisms, in spite of post-transcriptional modifications.
    Elbekai RH, El-Kadi AO.
    Toxicol In Vitro; 2008 Aug 15; 22(5):1184-90. PubMed ID: 18474416
    [Abstract] [Full Text] [Related]

  • 35. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).
    Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, Ross D.
    Br J Cancer; 1997 Aug 15; 75(1):69-75. PubMed ID: 9000600
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Studies of pyrrolo[1,2-alpha]benzimidazolequinone DT-diaphorase substrate activity, topoisomerase II inhibition activity, and DNA reductive alkylation.
    Skibo EB, Gordon S, Bess L, Boruah R, Heileman MJ.
    J Med Chem; 1997 Apr 25; 40(9):1327-39. PubMed ID: 9135030
    [Abstract] [Full Text] [Related]

  • 40. MDR quinone oxidoreductases: the human and yeast zeta-crystallins.
    Porté S, Crosas E, Yakovtseva E, Biosca JA, Farrés J, Fernández MR, Parés X.
    Chem Biol Interact; 2009 Mar 16; 178(1-3):288-94. PubMed ID: 19007762
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.